Xanthine oxidase inhibitors |
Allopurinol |
Reduces the level of blood uric acid [9] |
50–800 [9] |
(i) Digestive disorders |
(ii) Hypersensitivity syndrome |
(iii) Hepatotoxicity |
(iv) Skin reactions [14] |
Febuxostat |
Reduces the level of blood uric acid [9] |
80–120 [9] |
(i) Digestive disorders |
(ii) Headache |
(iii) Liver problems |
(iv) Rash in the skin [9] |
|
Uricosuric agents |
Probenecid |
Inhibition of the uric acid reabsorption [15] |
— |
(i) Gastrointestinal tract irritation |
(ii) Anorexia |
(iii) Skin reactions [9] |
Benzbromarone |
|
100 |
(i) Hepatotoxicity [16] |
Lesinurad |
Inhibition of the uric acid reabsorption [17] |
|
(i) Gastroesophageal reflux disease |
(ii) Headache |
(iii) Influenza associated with kidney failure [9] |
Losartan/fenofibrate |
Lowering urate formation [18] |
|
|
|
Uricases |
Rasburicase |
The recombinant form of uricases |
|
(i) Infusion problems [9] |
(ii) Antibody formation [19] |
(iii) Anaphylaxis [9] |